Mongolia

Mongolia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
4.28 (3.88 - 4.70) 2019 Modelled IHME
4.44 (4.02 - 4.86) 2018 Modelled IHME
4.55 (4.08 - 5.03) 2017 Modelled IHME
4.6 (4.12 - 5.03) 2016 Modelled IHME
4.65 (4.14 - 5.15) 2015 Modelled IHME
4.75 (4.22 - 5.24) 2014 Modelled IHME
4.9 (4.34 - 5.38) 2013 Modelled IHME
5.07 (4.47 - 5.56) 2012 Modelled IHME
5.22 (4.60 - 5.75) 2011 Modelled IHME
5.34 (4.67 - 5.89) 2010 Modelled IHME
5.42 (4.75 - 5.99) 2009 Modelled IHME
5.48 (4.81 - 6.05) 2008 Modelled IHME
5.54 (4.85 - 6.11) 2007 Modelled IHME
5.59 (4.88 - 6.20) 2006 Modelled IHME
5.65 (4.88 - 6.31) 2005 Modelled IHME
5.72 (4.95 - 6.40) 2004 Modelled IHME
5.78 (4.98 - 6.49) 2003 Modelled IHME
5.85 (4.98 - 6.57) 2002 Modelled IHME
5.92 (5 - 6.69) 2001 Modelled IHME
6.01 (5.01 - 6.83) 2000 Modelled IHME
6.13 (5.11 - 6.95) 1999 Modelled IHME
6.3 (5.28 - 7.14) 1998 Modelled IHME
6.48 (5.48 - 7.32) 1997 Modelled IHME
6.63 (5.65 - 7.51) 1996 Modelled IHME
6.73 (5.70 - 7.68) 1995 Modelled IHME
6.78 (5.71 - 7.73) 1994 Modelled IHME
6.83 (5.72 - 7.81) 1993 Modelled IHME
6.87 (5.72 - 7.90) 1992 Modelled IHME
6.9 (5.71 - 7.99) 1991 Modelled IHME
6.91 (5.70 - 8.12) 1990 Modelled IHME
10.8 (8.80 - 13.31) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.29 (0.20 - 0.36) 2019 Modelled IHME
0.31 (0.21 - 0.41) 2018 Modelled IHME
0.33 (0.22 - 0.43) 2017 Modelled IHME
0.32 (0.22 - 0.42) 2016 Modelled IHME
0.31 (0.21 - 0.40) 2015 Modelled IHME
0.33 (0.22 - 0.42) 2014 Modelled IHME
0.35 (0.24 - 0.46) 2013 Modelled IHME
0.4 (0.27 - 0.51) 2012 Modelled IHME
0.44 (0.29 - 0.58) 2011 Modelled IHME
0.49 (0.32 - 0.64) 2010 Modelled IHME
0.56 (0.36 - 0.73) 2009 Modelled IHME
0.64 (0.43 - 0.84) 2008 Modelled IHME
0.73 (0.49 - 0.95) 2007 Modelled IHME
0.8 (0.53 - 1.03) 2006 Modelled IHME
0.82 (0.55 - 1.07) 2005 Modelled IHME
0.82 (0.54 - 1.07) 2004 Modelled IHME
0.81 (0.52 - 1.07) 2003 Modelled IHME
0.79 (0.50 - 1.06) 2002 Modelled IHME
0.78 (0.48 - 1.06) 2001 Modelled IHME
0.78 (0.47 - 1.06) 2000 Modelled IHME
0.79 (0.49 - 1.08) 1999 Modelled IHME
0.84 (0.53 - 1.12) 1998 Modelled IHME
0.9 (0.59 - 1.19) 1997 Modelled IHME
0.99 (0.66 - 1.29) 1996 Modelled IHME
1.09 (0.75 - 1.41) 1995 Modelled IHME
1.29 (0.90 - 1.66) 1994 Modelled IHME
1.65 (1.13 - 2.14) 1993 Modelled IHME
2.12 (1.42 - 2.80) 1992 Modelled IHME
2.69 (1.78 - 3.60) 1991 Modelled IHME
3.3 (2.18 - 4.48) 1990 Modelled IHME
1.72 (1.14 - 2.57) 2015 Modelled WHO
0.5 2009 Survey/reported WHO WPRO, Woodring J et al, 2017
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
29.1 (20.30 - 39.90) 2019 Modelled IHME
29.1 (20.50 - 40) 2018 Modelled IHME
29 (20.60 - 39.80) 2017 Modelled IHME
28.6 (20.40 - 38.90) 2016 Modelled IHME
28 (20.20 - 38.10) 2015 Modelled IHME
27.9 (20.20 - 37.30) 2014 Modelled IHME
27.9 (20.60 - 36.90) 2013 Modelled IHME
28 (20.90 - 36.40) 2012 Modelled IHME
28.1 (21 - 36.20) 2011 Modelled IHME
28 (21 - 36.10) 2010 Modelled IHME
27.5 (20.60 - 35.20) 2009 Modelled IHME
26.8 (20.30 - 34.30) 2008 Modelled IHME
26.3 (19.90 - 33.40) 2007 Modelled IHME
25.8 (19.70 - 32.90) 2006 Modelled IHME
25.2 (19.20 - 32.40) 2005 Modelled IHME
24.8 (19 - 31.60) 2004 Modelled IHME
24.7 (18.90 - 31.70) 2003 Modelled IHME
24.6 (19 - 31.50) 2002 Modelled IHME
24.5 (18.90 - 31.40) 2001 Modelled IHME
24 (18.60 - 30.40) 2000 Modelled IHME
23.7 (18.40 - 29.70) 1999 Modelled IHME
23.8 (18.60 - 29.70) 1998 Modelled IHME
24 (18.90 - 30.10) 1997 Modelled IHME
24.3 (19.30 - 30.40) 1996 Modelled IHME
24.2 (19.20 - 30.40) 1995 Modelled IHME
24.1 (19 - 30) 1994 Modelled IHME
24.2 (19.10 - 30.10) 1993 Modelled IHME
24 (19 - 29.80) 1992 Modelled IHME
24 (19 - 29.90) 1991 Modelled IHME
23.9 (18.70 - 30) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
987 (689 - 1,351) 2019 Modelled IHME
970 (682 - 1,333) 2018 Modelled IHME
948 (672 - 1,301) 2017 Modelled IHME
917 (655 - 1,249) 2016 Modelled IHME
882 (636 - 1,199) 2015 Modelled IHME
859 (621 - 1,148) 2014 Modelled IHME
841 (620 - 1,113) 2013 Modelled IHME
826 (617 - 1,075) 2012 Modelled IHME
813 (607 - 1,046) 2011 Modelled IHME
794 (593 - 1,022) 2010 Modelled IHME
762 (572 - 977) 2009 Modelled IHME
729 (552 - 934) 2008 Modelled IHME
704 (534 - 895) 2007 Modelled IHME
680 (520 - 866) 2006 Modelled IHME
654 (500 - 841) 2005 Modelled IHME
635 (488 - 810) 2004 Modelled IHME
625 (479 - 802) 2003 Modelled IHME
616 (476 - 789) 2002 Modelled IHME
607 (468 - 778) 2001 Modelled IHME
587 (456 - 745) 2000 Modelled IHME
574 (445 - 721) 1999 Modelled IHME
571 (447 - 713) 1998 Modelled IHME
571 (450 - 716) 1997 Modelled IHME
572 (453 - 715) 1996 Modelled IHME
563 (445 - 707) 1995 Modelled IHME
552 (437 - 688) 1994 Modelled IHME
547 (432 - 681) 1993 Modelled IHME
536 (423 - 665) 1992 Modelled IHME
527 (418 - 656) 1991 Modelled IHME
515 (403 - 647) 1990 Modelled IHME
1,363 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
30 (22 - 39) 2019 Modelled IHME
30 (23 - 40) 2018 Modelled IHME
30 (23 - 39) 2017 Modelled IHME
30 (23 - 39) 2016 Modelled IHME
30 (23 - 39) 2015 Modelled IHME
31 (23 - 39) 2014 Modelled IHME
31 (23 - 39) 2013 Modelled IHME
31 (23 - 39) 2012 Modelled IHME
31 (24 - 39) 2011 Modelled IHME
31 (24 - 39) 2010 Modelled IHME
31 (24 - 39) 2009 Modelled IHME
31 (24 - 40) 2008 Modelled IHME
31 (24 - 40) 2007 Modelled IHME
31 (24 - 40) 2006 Modelled IHME
32 (24 - 40) 2005 Modelled IHME
32 (24 - 41) 2004 Modelled IHME
33 (25 - 42) 2003 Modelled IHME
33 (25 - 43) 2002 Modelled IHME
34 (26 - 44) 2001 Modelled IHME
35 (26 - 44) 2000 Modelled IHME
35 (27 - 45) 1999 Modelled IHME
35 (27 - 45) 1998 Modelled IHME
35 (27 - 45) 1997 Modelled IHME
35 (27 - 45) 1996 Modelled IHME
35 (27 - 45) 1995 Modelled IHME
35 (27 - 45) 1994 Modelled IHME
35 (27 - 45) 1993 Modelled IHME
35 (26 - 44) 1992 Modelled IHME
34 (26 - 44) 1991 Modelled IHME
34 (25 - 44) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
98 2018 Survey/reported WHO/UNICEF
98 2017 Survey/reported WHO/UNICEF
98 2016 Survey/reported WHO/UNICEF
97 2015 Survey/reported WHO/UNICEF
97 2014 Survey/reported WHO/UNICEF
97 2013 Survey/reported WHO/UNICEF
97 2012 Survey/reported WHO/UNICEF
96 2011 Survey/reported WHO/UNICEF
95 2010 Survey/reported WHO/UNICEF
98 2009 Survey/reported WHO/UNICEF
94 2008 Survey/reported WHO/UNICEF
97 2007 Survey/reported WHO/UNICEF
98 2006 Survey/reported WHO/UNICEF
89 2005 Survey/reported WHO/UNICEF
98 2004 Survey/reported WHO/UNICEF
99 2003 Survey/reported WHO/UNICEF
98 2002 Survey/reported WHO/UNICEF
98 2001 Survey/reported WHO/UNICEF
96 2000 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
99 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
98 2013 Survey/reported WHO/UNICEF
99 2012 Survey/reported WHO/UNICEF
99 2011 Survey/reported WHO/UNICEF
96 2010 Survey/reported WHO/UNICEF
97 2009 Survey/reported WHO/UNICEF
96 2008 Survey/reported WHO/UNICEF
98 2007 Survey/reported WHO/UNICEF
98 2006 Survey/reported WHO/UNICEF
98 2005 Survey/reported WHO/UNICEF
98 2004 Survey/reported WHO/UNICEF
98 2003 Survey/reported WHO/UNICEF
98 2002 Survey/reported WHO/UNICEF
95 2001 Survey/reported WHO/UNICEF
93 2000 Survey/reported WHO/UNICEF
92 1999 Survey/reported WHO/UNICEF
91 1998 Survey/reported WHO/UNICEF
88 1997 Survey/reported WHO/UNICEF
93 1996 Survey/reported WHO/UNICEF
88 1995 Survey/reported WHO/UNICEF
67 1994 Survey/reported WHO/UNICEF
69 1993 Survey/reported WHO/UNICEF
47 1992 Survey/reported WHO/UNICEF
18 1991 Survey/reported WHO/UNICEF
Showing out of
Show more

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
Source:
Year of HBV elimination goal
2030
Source:
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2002
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Source:
Year of HCV elimination goal
2020
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
9.34 (7.16 - 12.08) 2019 Modelled IHME
9.4 (7.25 - 12.30) 2018 Modelled IHME
9.49 (7.26 - 12.61) 2017 Modelled IHME
9.67 (7.43 - 12.78) 2016 Modelled IHME
9.88 (7.34 - 13.19) 2015 Modelled IHME
10.11 (7.57 - 13.37) 2014 Modelled IHME
10.4 (7.81 - 13.61) 2013 Modelled IHME
10.67 (8.11 - 13.80) 2012 Modelled IHME
10.88 (8.28 - 13.95) 2011 Modelled IHME
10.96 (8.33 - 14.12) 2010 Modelled IHME
10.84 (8.26 - 13.85) 2009 Modelled IHME
10.53 (8.07 - 13.33) 2008 Modelled IHME
10.15 (7.82 - 12.71) 2007 Modelled IHME
9.79 (7.55 - 12.20) 2006 Modelled IHME
9.58 (7.39 - 11.97) 2005 Modelled IHME
9.47 (7.42 - 11.73) 2004 Modelled IHME
9.37 (7.41 - 11.49) 2003 Modelled IHME
9.29 (7.34 - 11.41) 2002 Modelled IHME
9.23 (7.37 - 11.33) 2001 Modelled IHME
9.21 (7.35 - 11.34) 2000 Modelled IHME
9.2 (7.37 - 11.33) 1999 Modelled IHME
9.2 (7.40 - 11.39) 1998 Modelled IHME
9.2 (7.39 - 11.43) 1997 Modelled IHME
9.2 (7.37 - 11.47) 1996 Modelled IHME
9.2 (7.31 - 11.50) 1995 Modelled IHME
9.19 (7.33 - 11.51) 1994 Modelled IHME
9.18 (7.35 - 11.50) 1993 Modelled IHME
9.16 (7.29 - 11.45) 1992 Modelled IHME
9.15 (7.29 - 11.41) 1991 Modelled IHME
9.13 (7.26 - 11.42) 1990 Modelled IHME
6.4 (4.30 - 7.90) 2015 Modelled Blach et al, 2017
7.5 (6.10 - 10.90) 2014 Modelled Gower et al, 2014
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
10.8 (8.70 - 15.60) 2014 Modelled Gower et al, 2014
10.8 (8.70 - 15.60) 2014 Modelled Gower et al, 2014
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
30.8 (22.50 - 41) 2019 Modelled IHME
30.2 (22.20 - 39.80) 2018 Modelled IHME
29.7 (21.90 - 39.30) 2017 Modelled IHME
29.5 (21.70 - 39.20) 2016 Modelled IHME
28.8 (21.50 - 38.20) 2015 Modelled IHME
28.7 (21.80 - 37.70) 2014 Modelled IHME
28.8 (21.90 - 37.60) 2013 Modelled IHME
29 (22 - 37.60) 2012 Modelled IHME
29.4 (22.10 - 37.90) 2011 Modelled IHME
29.3 (22.20 - 37.50) 2010 Modelled IHME
28.7 (21.90 - 36.50) 2009 Modelled IHME
28 (21.30 - 35.50) 2008 Modelled IHME
27.5 (21.10 - 34.70) 2007 Modelled IHME
26.9 (20.50 - 34.30) 2006 Modelled IHME
25.9 (19.60 - 33.20) 2005 Modelled IHME
24.7 (18.80 - 31.70) 2004 Modelled IHME
23.4 (17.70 - 30.10) 2003 Modelled IHME
21.8 (16.30 - 28.30) 2002 Modelled IHME
20.4 (15.20 - 26.80) 2001 Modelled IHME
18.9 (14 - 24.70) 2000 Modelled IHME
17.9 (13.30 - 23.50) 1999 Modelled IHME
17.4 (13 - 22.70) 1998 Modelled IHME
17.1 (13 - 22.40) 1997 Modelled IHME
17.1 (13 - 22.50) 1996 Modelled IHME
16.9 (12.80 - 22) 1995 Modelled IHME
16.7 (12.80 - 21.60) 1994 Modelled IHME
16.9 (12.90 - 21.90) 1993 Modelled IHME
17.1 (13.20 - 21.90) 1992 Modelled IHME
17.3 (13.30 - 22.10) 1991 Modelled IHME
17.4 (13.10 - 22.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
1,044 (763 - 1,389) 2019 Modelled IHME
1,005 (740 - 1,326) 2018 Modelled IHME
973 (715 - 1,284) 2017 Modelled IHME
945 (698 - 1,258) 2016 Modelled IHME
905 (677 - 1,202) 2015 Modelled IHME
882 (670 - 1,161) 2014 Modelled IHME
870 (660 - 1,133) 2013 Modelled IHME
857 (649 - 1,110) 2012 Modelled IHME
848 (638 - 1,094) 2011 Modelled IHME
830 (627 - 1,061) 2010 Modelled IHME
796 (607 - 1,013) 2009 Modelled IHME
762 (580 - 968) 2008 Modelled IHME
735 (566 - 929) 2007 Modelled IHME
710 (540 - 903) 2006 Modelled IHME
674 (510 - 862) 2005 Modelled IHME
634 (481 - 811) 2004 Modelled IHME
593 (449 - 762) 2003 Modelled IHME
547 (407 - 708) 2002 Modelled IHME
505 (376 - 664) 2001 Modelled IHME
462 (343 - 605) 2000 Modelled IHME
433 (323 - 569) 1999 Modelled IHME
417 (313 - 546) 1998 Modelled IHME
407 (308 - 532) 1997 Modelled IHME
402 (304 - 528) 1996 Modelled IHME
392 (298 - 511) 1995 Modelled IHME
384 (293 - 496) 1994 Modelled IHME
382 (292 - 495) 1993 Modelled IHME
380 (293 - 488) 1992 Modelled IHME
379 (291 - 485) 1991 Modelled IHME
374 (283 - 477) 1990 Modelled IHME
603 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
30 (21 - 38) 2019 Modelled IHME
30 (21 - 38) 2018 Modelled IHME
30 (21 - 38) 2017 Modelled IHME
30 (22 - 38) 2016 Modelled IHME
30 (22 - 38) 2015 Modelled IHME
30 (22 - 38) 2014 Modelled IHME
30 (22 - 39) 2013 Modelled IHME
30 (22 - 39) 2012 Modelled IHME
31 (23 - 39) 2011 Modelled IHME
31 (23 - 39) 2010 Modelled IHME
31 (23 - 39) 2009 Modelled IHME
31 (23 - 40) 2008 Modelled IHME
31 (23 - 40) 2007 Modelled IHME
31 (23 - 40) 2006 Modelled IHME
31 (23 - 40) 2005 Modelled IHME
31 (23 - 40) 2004 Modelled IHME
31 (22 - 40) 2003 Modelled IHME
30 (22 - 39) 2002 Modelled IHME
30 (22 - 39) 2001 Modelled IHME
30 (21 - 38) 2000 Modelled IHME
29 (21 - 38) 1999 Modelled IHME
29 (21 - 38) 1998 Modelled IHME
29 (21 - 38) 1997 Modelled IHME
29 (21 - 38) 1996 Modelled IHME
29 (21 - 39) 1995 Modelled IHME
30 (21 - 39) 1994 Modelled IHME
30 (21 - 39) 1993 Modelled IHME
30 (22 - 40) 1992 Modelled IHME
31 (22 - 40) 1991 Modelled IHME
31 (22 - 41) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
Source:
Year of HBV elimination goal
2030
Source:
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2002
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Source:
Year of HCV elimination goal
2020
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Source: WHO

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2020

Prevalence (national)

Modelled

HBV (HBsAg+)
4.28 (%)
2019
(3.88 - 4.7(%))
IHME
HCV (RNA/cAg+)
9.34 (%)
2019
(7.16 - 12.08(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
987
2019
(689 - 1,351)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
1,044
2019
(763 - 1,389)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.29 (%)
2019, latest modelled
(0.20 - 0.36(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
98 (%)
2018
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources

Programs

Partners